Drug Trial Radar · NCT03901482
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate STS101 in the Acute Treatment of Migraine
Last checked: Nov 19, 2026Latest source record: Jun 29, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,201
Actual
Start
Jun 24, 2019
Primary completion
Jul 31, 2020
Study completion Aug 13, 2020
Sponsor
- Lead sponsor
- Satsuma Pharmaceuticals, Inc.Industry
- Sponsor type
- Industry
- First posted
- Apr 3, 2019
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Study STS101-002 is a randomized, double-blind, parallel group, placebo-controlled, multicenter study to evaluate the efficacy, safety, and tolerability of single doses of STS101 (dihydroergotamine nasal powder) in the acute treatment of migraine
Conditions
- Migraine
- Migraine With Aura
- Migraine Without Aura
Interventions
DihydroergotamineDrug
Dihydroergotamine is a semi-synthetic derivative of ergotamine tartrate.
PlacebosDrug
Placebo for STS101
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Subjects With Freedom From Migraine Headache Pain at 2 Hours Post DoseTime frame: 2 Hours Post-Dose
- Percentage of Subjects With Freedom From Most-Bothersome Symptom at 2 Hours Post DoseTime frame: 2 Hours Post-Dose
Locations
117 sites in 1 country. Site status is shown where the registry gives one.
Accel Clinical - Birmingham
Birmingham, Alabama
Alabama Clinical Therapeutics
Birmingham, Alabama
Alea Research
Phoenix, Arizona
Elite Clinical Studies
Phoenix, Arizona
Arizona Research Center
Phoenix, Arizona
Tucson Neuroscience Research
Tucson, Arizona
The Research Center of Southern California
Carlsbad, California
Med Center Medical Clinic
Carmichael, California
WR-PRI
Encino, California
Marvel Clinical Research
Huntington Beach, California
eStudySite
La Mesa, California
Collaborative Neuroscience
Long Beach, California
WP-PRI
Los Alamitos, California
Downtown LA Research
Los Angeles, California
Cal Neuro Research Group
Los Angeles, California
WR-PRI
Newport Beach, California
Alliance Sites
Oakland, California
Stanford Neuroscience Health Center
Palo Alto, California
National Research Institute
Panorama City, California
Empire Clinical Reserch
Pomona, California
Artemis Institute for Clinical Research- Riverside
Riverside, California
Artemis Institute of Clinical Research - San Diego
San Diego, California
Pacific Research Network
San Diego, California
WR-MCCR
San Diego, California
Optimus Medical Group
San Francisco, California
Artemis Institute for Clinical Research- San Marcos
San Marcos, California
Neurological Research Institute
Santa Monica, California
Schuster Medical Research Institute
Sherman Oaks, California
Southern California Research
Simi Valley, California
Encompass Clinical Research
Spring Valley, California
Hartford Headache Center
East Hartford, Connecticut
CMR of Greater New Haven
Hamden, Connecticut
New England Institute for Neurology and Headache
Stamford, Connecticut
Chase Medical Research
Waterbury, Connecticut
Accel Clinical - DeLand
DeLand, Florida
Gulf Coast Clinical Research
Fort Myers, Florida
MD Clinical
Hallandale, Florida
AGA Clinical Trials
Hialeah, Florida
Galiz Research- Hialeah
Hialeah, Florida
Research Centers of America
Hollywood, Florida
Showing 40 of 117 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.